Login

Sienna Cancer Diagnostics (ASX:SDX) update - Matthew Hoskin, CEO, Sienna Cancer Diagnostics Ltd 00:00:00

Share On Facebook Share On Twitter

Sienna Cancer Diagnostics, CEO, Matthew Hoskin provides an update

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Builders FirstSource CEO Dave Rush on Real Estate Trends and the State of Home Builders | Dave Rush, CEO, Builders FirstSource Inc.
00:00:00
Richard DiIorio Chief Executive Officer, InfuSystem Holdings Inc
00:10:00
Private Equity in Sri Lanka: Opportunities for Growth and Investment Insights from Zephyr Management's Thomas Barry
00:10:00
Nano Dimension's CEO, Yoav Stern, discusses the strategic acquisition of DeepCube Ltd. to enhance AI capabilities for advanced manufacturing.|Yoav Stern, CEO of Nano Dimension
00:10:00
Impact of JobKeeper and JobSeeker on Customers, Government's Role in Energy Sector, and Investment Uncertainty | Frank Calabria, CEO, Origin Energy Ltd .
00:10:00
Timm Schneider ZignSec Pitch | CEO at ZignSec | Glenn Donald, CEO, ZignSec AB (publ)ZIGN:STO
00:10:00
Revival Gold: Building a Growth Company in Idaho
00:10:00
Melior Resources: Restarting Ilmenite Production at Gunda Camile with Strong Financing and Market Potential
00:10:00
Evolving Financial Planning for Client Success with Eric Simonson | Eric Simonson - CEO of Abundo Wealth
00:10:00
Vijay Chandok of ICICI Securities discusses the sustained growth in derivatives income and initiatives to expand the business on ET NOW.
00:10:00
Interview with Valeria Sandei, CEO Almawave | Valeria Sandei, CEO, Almawave SpAAIW:MIL
00:10:00
Copper Market Outlook: Post-COVID-19 Recovery and Future Projections

© 2017 - Neuhu+